Skip to main content

Table 1 Patient demographics and prescription status

From: Potentially harmful excipients in neonatal medications: a multicenter nationwide observational study in Japan

Patients information
 Facilities 22   
 Case 343   
 Gestational age (weeks), median (range) 31.9 (21.4–41.4)   
 Postnatal age (days), median (range) 17 (0–267)   
 Birth weight (g), median (range) 1470 (280–4030)   
 Bodyweight at dose (g), median (range) 1972 (410–7505)   
 PMA (weeks), median (range) 36.0 (23.3–71.1)   
Prescription information No. (%) of neonates No. (%) of prescriptions No. (%) of products
 Total 343 2360 426
  Parenteral 225 (65.6%) 1475 (62.5%) 291 (68.3%)
  Enteral 200 (58.3%) 763 (32.3%) 104 (24.4%)
  Topical 82 (23.9%) 122 (5.2%) 31 (7.3%)